Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Rasagiline
Drug ID BADD_D02441
Description Rasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases.
Indications and Usage For the treatment of the signs and symptoms of idiopathic Parkinsons disease as initial monotherapy and as adjunct therapy to levodopa.
Marketing Status Not Available
ATC Code N04BD02
DrugBank ID DB01367
KEGG ID D08469
MeSH ID C031967
PubChem ID 3052776
NDC Product Code 42291-779; 67877-259; 47781-690; 0093-3061; 67877-260; 42291-780; 47781-683; 42571-220; 16714-771; 16714-770; 0093-3060; 42571-221
Synonyms rasagiline | N-2-propynyl-1-indanamine | AGN 1135 | AGN-1135 | TVP 1022 | TVP1022 | TVP-1022 | N-propargyl-1-aminoindan mesylate | rasagiline hydrochloride | TVP 101 | TVP-101 | 2,3-dihydro-N-2-propynyl-1H-inden-1-amine-(1R)-hydrochloride | Azilect
Chemical Information
Molecular Formula C12H13N
CAS Registry Number 136236-51-6
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.0020.018605%
Acute myocardial infarction24.04.04.001; Available
Affective disorder19.04.04.0010.007442%Not Available
Aggression19.05.01.0010.011163%Not Available
Akinesia17.01.02.0030.011163%Not Available
Altered state of consciousness19.07.01.003; Available
Angina pectoris24.04.04.002;
Asthenia08.01.01.0010.029768%Not Available
Atrial fibrillation02.03.03.0020.018605%
Back pain15.03.04.0050.014884%
Blood pressure decreased13.14.03.0020.007442%Not Available
Blood pressure fluctuation24.06.01.0020.007442%Not Available
Blood pressure increased13.14.03.0050.018605%Not Available
Bradycardia02.03.02.0020.007442%Not Available
Bradykinesia17.01.02.0040.007442%Not Available
Cardiac arrest02.03.04.0010.003883%
Cardio-respiratory arrest22.02.06.007; Available
Cardiovascular disorder24.03.02.009; Available
Cerebral haemorrhage17.08.01.003; Available
Cerebral infarction24.04.06.002; Available
Chest pain08.01.08.002;; Available
Coma17.02.09.0010.007442%Not Available
Completed suicide19.12.01.001; Available
Confusional state17.02.03.005;
The 1th Page    1 2 3 4 5    Next   Last    Total 6 Pages